Eric M Lander

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Locally Advanced

Patient Reported Outcomes

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist 28 (2) (2023)
Eric M Lander, Katherine C Rappazzo, Li-Ching Huang, Jiun-Ruey Hu, Heidi Chen, Yu Shyr, Vandana G Abramson
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer. The oncologist (2022)